Hysterectomy. Acquired absence of genital organ(s)
Conditions
Interventions
Intervention 1: Intervention group 1: 1 µg/kg of dexmedetomidine in 15 minutes and then 2 µg/kg/hour till the end of operation. Intervention 2: Intervention group 2: 1 µg/kg/minute of remifentanil unt
Treatment - Drugs
Intervention group 1: 1 µg/kg of dexmedetomidine in 15 minutes and then 2 µg/kg/hour till the end of operation
Intervention group 2: 1 µg/kg/minute of remifentanil until end of the operation
Sponsors
Vice-chancellor for Research, Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
2 Days to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients candidate for elective hysterectomy operation in Firozgar hospital; ASA I-II grade; informed consent Exclusion criteria: patients above 70 years of age; emergency operation; patients with cardiopulmonary disease; renal disease; hepatic disease; diabetes; hypertension; obesity; difficult airway; lactating women; sleep apnea; psychological diseases
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consciousness. Timepoint: After recovery. Method of measurement: Aldrete questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic parameters. Timepoint: Every two hours from beginning of the operation and after the operation. Method of measurement: Barometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Faranak Rokhtabnak
Iran University of Medical Sciences
Outcome results
None listed